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There is a similarity in the ap-
proach taken by Dr. Wolf (Dr. 
Stewart G .,- the 1967 Stoneburner 
Lecturer) and Col. Moser to the 
one I will present to you. Dr. Wolf 
is interested in why some people 
die suddenly and why others do 
not. What are the factors responsi-
ble for predisposition? The major 
theme of our studies on the epi-
demiology of adverse drug reac-
tions has been to gain understand-
ing of why some people will have 
trouble and others will not when 
given the same drugs in essentially 
the same way and for the same rea-
sons. Col. Moser spoke to the 
problem of adverse drug reactions, 
i.e., their recognition, identifica-
tion, and documentation. Epidemi-
ological methods allow us to iden-
tify reactions, when they occur, 
and to establish the risk involved 
in administration of drugs to pa-
tients. 
In any epidemiological study 
there are two pieces of information 
that must be accumulated. One is 
denominator data and the other is 
numerator data. When we began 
our studies about five years ago, 
our initial attention was directed 
toward assembling denominator 
data. How many drugs are used? 
What patients receive them? Under 
what circumstances? These data 
identified the population at risk. 
One should also know the dosage 
form in which the drug is adminis-
tered, and have information on 
the duration of therapy. Unfor-
tunately, the latter two pieces of 
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information are difficult to obtain, 
because, as Col. Moser has pointed 
out, the accumulation of masses of 
information on patients at risk and 
the drugs they receive is an over-
whelming task requiring automatic 
data processing. At present, in 
most hospitals, it is impossible to 
retrieve information on dosage 
form or duration of therapy, al-
though in most instances it is pos-
sible to identify the population at 
risk receiving given groups of 
drugs. 
Drug Usage in Hospitals 
I will summarize some of the 
pertinent observations that we have 
made during the course of our in-
vestigations. 
The most frequently used drugs 
in a hospital, as you might expect, 
are tranquilizers and sedatives. It 
is interesting, however, in refer-
ence to Col. Moser's paying partic-
ular attention to tetracycline, that 
in one survey at the Johns Hopkins 
Hospital, five of the ten most com-
monly prescribed drugs were anti-
microbial agents. 
The studies that I will speak 
about were confined largely to an 
evaluation of drug usage and ad-
verse reactions to drugs on a medi-
cal service at the Johns Hopkins 
Hospital. This included an evalua-
tion of private and public patients. 
The results were in essence identi-
cal, so there is no point in differ-
entiating them. 
On the medical service at the 
Johns Hopkins Hospital the aver-
age number of drugs given to a 
patient during hospitalization was 
11. This ranged from zero to 42 
different drugs. We have identified 
only one patient who received no 
medication during hospitalization. 
It is interesting to evaluate the 
kinds of drugs patients receive. In 
one study, evaluating all the pa-
tients in the hospital receiving 
methicillin, we identified a patient 
who received 37 different drugs, 
and this patient received five dif-
ferent antimicrobial agents during 
the course of hospitalization. In 
other university medical centers, 
the average number of drugs ad-
ministered to patients on medical 
services is about 10 to 14 different 
medications during hospitalization. 
Examining drug usage can be a 
useful exercise. It's not just a col-
lection of meaningless data. I 
would like to point out one ex-
ample of how this was important at 
Johns Hopkins Hospital. 
During the initial phase of our 
study on drug usage, we became 
aware that the surgical service used 
the most chloramphenicol in the 
hospital. We investigated the pa-
tients on the surgical service who 
received chloramphenicol. Most of 
the patients received the drug pro-
phylactically, in an attempt to pre-
vent wound infections. But the in-
teresting thing was to determine 
why chloramphenicol was being 
used as a prophylactic drug, when 
this is not considered advisable. 
Two years before, one of the sur-
geons on the staff had done a study 
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of the effectiveness of chloram-
phenicol in prevention of postop-
erative wound infections. He had 
instituted a study with a double-
blind placebo and the housestaff 
administered the drugs in random 
fashion to the patients on the serv-
ice, some getting chloramphenicol 
and some getting placebo. The 
study was conducted for six 
months. The surgeon evaluated his 
data, found no difference in the 
frequency of wound infections, and 
terminated his study. By this time, 
the surgical staff had become ac-
customed to using chloramphenicol 
prophylactically, however, and the 
practice was perpetuated. When 
this was brought to the attention 
of the surgeon-in-chief, some cur-
tailment in the use of chloram-
phenicol was possible. 
Detection of Adverse Drug 
Reactions 
Identification of adverse drug re-
actions, when patients receive 11 
different drugs, is a problem. When 
a reaction occurs or when some 
anticipated illness develops how 
can the physician 1) be certain 
that it is an adverse reaction to 
a drug, and 2) identify the specific 
drug responsible for the adverse 
effect. When a patient develops a 
febrile reaction or granulocytopenia 
during hospitalization, and he is 
receiving 42 different drugs, you 
tell me which one is involved! We 
can go to the literature and identify 
those drugs incriminated previously, 
but we may overlook the one that 
is specifically involved. 
Methods of Detection 
What are some of the methods 
that can be employed for detection 
of adverse reactions? The AMA 
Registry on Drugs and the Food 
and Drug Administration are using 
voluntary reporting, the system we 
initially adopted. In epidemiolog-
ical studies, however, one needs 
a complete numerator and denom-
inator. Otherwise incidence and 
rates cannot be accurately deter-
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mined. We instituted a voluntary 
reporting system throughout the 
Johns Hopkms Hospital for one 
year. The average number of ad-
verse reactions reported initially 
was 15 per month. It gradually 
went up to 25 per month at the 
end of the year. We thought this 
was under-reporting, so an effort 
was made to examine the records 
of patients upon whom reports had 
been obtained, as well as those on 
whom reports had not been ob-
tained. Only one-tenth of all sig-
nificant adverse reactions had been 
reported voluntarily. Obviously vol-
untary reporting is incomplete. Us 
greatest usefulness is in the identi-
fication of previously unrecognized 
ill effects of a drug. 
The only way to collect com-
plete data is by personalized sur-
veillance. This can be done, pro-
spectively or retrospectively, and we 
have done both. A retrospective 
analysis is notoriously inadequate. 
To evaluate this we selected the 
records of patients who had been 
given Warfarin. The ill effects of 
anticoagulant drugs are readily 
identifiable. In a retrospective 
analysis 10% of the patients who 
received this anticoagulant drug 
had some manifestation of bleed-
ing, gross or microscopic. The 
commonest site of bleeding, of 
course, was in the urine. Most 
commonly the bleeding was micro-
scopic. Occasionally, blood was 
found in the feces, but subarach-
noid hemorrhage and massive 
bleeding into the pleural space fol-
lowing thoracentesis was demon-
strable. This method too, however, 
was an inadequate way of obtain-
ing data, because doctors are not 
good at recording reactions in pa-
tients' charts. This is illustrated by 
the fact that the majority of the 
patients rece1vmg Wafarin had 
one urinalysis and had one stool 
examination for occult blood done 
during hospitalization and that was 
the day of admission. Generally 
these examinations were not re-
peated. The necessary tests were 
not done to detect the most com-
mon sites of bleeding in patients 
receiving anticoagulants. 
Personalized prospective surveil-
lance was the only way to obtain 
complete information. Three 
methods have been evaluated: 1) 
surveillance of all patients receiv-
ing a particular drug in the hos-
pital; 2) surveillance of all patients 
with a particular disease in the 
hospital, the drugs they receive, 
and the reactions they may de-
velop; 3) surveillance of groups of 
patients, such as those on a medi-
cal service or surgical service. The 
latter is the one that has proven, 
in our hands, the most useful in un-
covering information relevant to 
the factors that predispose patients 
to reactions. 
Definition of a Reaction 
Another problem is the defini-
tion of a reaction. It can be de-
fined by mechanism involved, clin-
ical features, or in terms of severity 
or probability. Severity is relatively 
easy to note: 1) fatal or life-
threatening; 2) requiring an anti-
dote or long hospitalization; and 3) 
an annoyance. The real difficulty 
is documenting the probability of 
a reaction. These are the systems 
that we have employed : 1) A docu-
mented reaction is one known to 
occur, with a clear temporal as-
sociation with the administration 
of the drug; on re-cha11enge the 
patient has a recurrence of the re-
action; or there is some confirma-
tory laboratory test establishing 
that the drug is incriminated in 
the patient's illness. 2) Probable 
reactions that have a temporal re-
lationship, are known to occur and 
disappear on withdrawal of the 
medication. We have ignored other 
reactions which are possible, be-
cause we cannot in those instances 
establish this as an adverse drug 
effect. 
I would like to show you ex-
amples of problems in identifying 
drug reactions. A 6-year-old boy 
with a tetralogy of Fallot was seen 
in the hospital for surgical cor-
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rection of his cardiac defect. He 
was put on penicillin and strepto-
mycin prophylactically. Following 
operation he developed progres-
sively increasing fever, leukocy-
tosis, mild anemia, weight loss, and 
anorexia. He had multiple blood 
cultures taken which were nega-
tive. He had no splenomegaly, nor 
did he have microscopic hema-
turia or petechiae, but the surgeons 
felt that he must have a post-
cardiotomy infection. The dosages 
of the anti-microbial drugs were 
increased, and others were added. 
The therapy was continued for 
seven weeks at which time I was 
called in consultation. It was sug-
gested that the patient might have 
drug fever. Streptomycin, tetracy-
cline, and erythromycin were 
stopped without any termination in 
the patient's course. Eight hours 
after the penicillin was stopped, the 
patient was afebrile and left the 
hospital four days later. This boy 
had fever as the only manifestation 
of the ill effects of a drug, and 
this was confused with infection. 
A young woman was seen in the 
emergency room because of a 
streptococcal sore throat. She was 
given penicillin. Within 48 hours, 
she returned to the emergency 
room with a florid confluent ery-
thematous rash, and a diagnosis 
of scarlet fever was made. The girl 
did not have scarlet fever. Follow-
ing recovery, after discontinuing 
her treatment, she was given peni-
cillin again and had a recurrence 
of the reaction. Again identifica-
tion of a reaction and differentiat-
ing it from a naturally occurring 
disease complicated the identifica-
tion of a drug reaction. 
Adverse Reactions Occurring 
in Hospitals 
With this as background, let's 
look at the overall problem of ad-
verse drug reactions in the hospital. 
On the medical service of the Johns 
Hopkins Hospital 5% of all the 
patients are admitted to the hos-
pital with an adverse drug reaction. 
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Four percent of the patients are 
admitted to the medical service, 
because of adverse effects of drugs. 
Adverse drug reactions as a cause 
of hospitalization represent the 
seventh most common reason for 
admission to the medical service. 
Of those patients admitted to the 
hospital who have a reaction at the 
time of admission, 30% will have 
a reaction to another drug during 
the course of hospitalization. This 
contrasts with an overall rate of re-
actions to drugs of 10% in all pa-
tients on the medical service. This 
means that the patient who has 
had a reaction to a medication has 
a three-fold greater likelihood of 
having a reaction to another drug 
during the course of hospitaliza-
tion. This identifies patients with 
a pronounced predisposition to the 
occurrence of reactions. 
A patient with miliary tubercu-
losis who was comatose when ad-
mitted to the hospital, was put on 
INH, P ASA, and streptomycin. 
During the course of the first five 
or six days of hospitalization she 
defervesced, and regained con-
sciousness. She developed an ex-
foliative rash and because of this 
it was necessary to stop all of her 
medication. At that time her tem-
perature declined and her exfolia-
tive rash disappeared. She still had 
her miliary tuberculosis, so she 
was put back on INH, but this 
time she developed a folicular 
rash over the face. An industrious 
intern aspirated one of these and 
grew a Staphylococcus albus. He 
was alarmed that the patient might 
be developing staphylococcal sep-
sis, and gave the patient an injection 
of penicillin. She went into ana-
phylactic shock, requiring hydro-
cortisone and norepinephrine. All 
drugs were again stopped, except 
that steroid and digitalis were con-
tinued. Again, the patient required 
treatment for her tuberculosis. 
While on prednisone she was given 
a single dose of P ASA and had a 
frank chill with a prompt rise in 
temperature. Subsequently, she was 
given a single dose of streptomy-
cin, and again had a prompt chill 
and recurrence of fever. During 
the course of these 70 days of hos-
pitalization, this patient had docu-
mented reactions, to paraminosali-
cylic acid, penicillin, streptomycin, 
and INH. 
I would like to return briefly to 
the problem of severity. Not all 
reactions to drugs seen in hospitals 
are mild. Mild reactions account 
for almost half of those observed. 
Correspondingly almost half of the 
patients had reactions sufficiently 
severe to warrant the physician's 
giving an antidote, prolong hos-
pitalization or to threaten life. 
Seven percent of the patients with 
adverse reactions had life-threaten-
ing or fatal reactions. 
Gastrointestinal rea.ctions to 
drugs are particularly common in 
women. In a report by Jordan and 
Dingle, women with colds also 
have an increased frequency of 
nausea, vomiting, and diarrhea. 
Whether this is a specific effect of 
drug reactions or whether it is a 
peculiarity of females, I don't 
know. Nevertheless, in all of our 
subsequent studies we have elimi-
nated the minor gastrointestinal re-
actions, because we cannot be cer-
tain of the relationship to the drug 
itself. It should be emphasized, 
however, that adverse effects of 
drugs frequently mimic natural dis-
ease. 
Tranquilizers and sedatives rank 
far above any other drugs as causes 
of ill effects in patients. Antimi-
crobial and cardiac drugs, however, 
are near in importance of ill effects 
in hospitalized patients. There is 
wide variation in rates of reactions 
to different drugs. The range was 
from 27% (probenecid) down to 
3.1% (mercaptomerin). Col. 
Moser made the point that before 
the physician can significantly 
weigh benefit with risk, he must 
have such data as this, citing inci-
dence as well as severity. Unfor-
tunately, such data is usually lack-
ing at the present time. In contrast 
to Col. Moser, however, I do not 
believe the present systems of the 
AMA Council on Drug and the 
Food and Drug Administration will 
get us to the point of determining 
the exact risk. 
Severity of Reactions 
Patients do die of drug reactions 
in the hospital. During one three-
month period on the medical serv-
ice of the Johns Hopkins Hospital, 
there were five deaths due to drugs 
in hospitalized patients. It is pos-
sible for the physician to avoid 
some of these lethal effects as il-
1 ustrated by these patients. A mid-
dle-aged man admitted to the 
hospital with chronic pulmonary 
disease had a coin lesion in his lung. 
During the course of his hospitali-
zation it was decided that he should 
be bronchoscoped. The pre-bron-
choscopic medications were pro-
mazine, pentobarbital, and mor-
phine. This medication was given 
and he was taken to the endoscopy 
room where he developed respira-
tory arrest. He was given artificial 
respiration and returned to the 
ward without bronchoscopy with 
the advice of the endoscopist that 
the patient should not be broncho-
scoped because of the problem of 
premedication. Two weeks later 
there was a change of physicians 
on the ward. They were fully aware 
that the patient shouldn't be bron-
choscoped, but they needed a study 
to identify the nature of his pul-
monary disease. A bronchogram 
was decided upon. The pre-medica-
tions for bronchography were pro-
mazine, pentobarbital, and mor-
phine, of which the physicians on 
the ward were unaware. The pre-
medication was given, and within 
a very short time the man went into 
shock, cardiac arrest, respiratory 
depression, and died. Another pa-
tient was a young woman who dur-
ing her prepartum period on the 
obstetrical service had been found 
to have a minor urinary tract infec-
tion and was given sulfisoxazole. 
Her bacteriuria cleared, but she de-
veloped an urticaria! and erythe-
matous rash. A note was written 
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in the progress notes by the obste-
trician that the patient was allergic 
to sulfonamides and the drug was 
discontinued. Following delivery, 
the woman was again found to 
have bacteriuria. She was now no 
longer an obstetrical patient and 
was referred to the medical clinic 
for evaluation. The obstetrical rec-
ords were kept in a different part 
of the chart from the medical rec-
ords. Frequently the internist 
doesn't read the obstetrician's 
notes. Nevertheless, the internist 
recognized the bacteriuria and re-
prescribed sulfisoxazole. Very 
shortly thereafter she had gross 
hematuria. She was admitted to the 
hospital hypertensive, had sulfona-
mide crystalluria, and died in renal 
failure. Autopsy revealed she had 
typical sulfonamide crystals in the 
tubules of her kidney. She un-
doubtedly died of sulfonamide-in-
duced allergic vasculitis. This ill-
ustrates some of the settings in 
which lethal effects of drugs can be 
observed and how they can be 
avoided. 
We have been unable to confirm 
any relationship in the patient with 
atopy and the subsequent develop-
ment of allergic or other reactions 
to drugs. However, history of an 
adverse reaction to any drug is as-
sociated with a significant increase 
in the frequency of reactions to 
other drugs subsequently adminis-
tered. So there is something pecul-
iar about people who have trouble 
with drugs. Whether this is herit-
able or what the factors are that 
are particularly involved remains to 
further study. 
Number of Drugs Administered 
An important factor related to 
the occurrence of adverse reactions 
to drugs in hospitalized patients is 
the number of drugs administered. 
When one exceeds a total of six 
drugs there is a logarithmic in-
crease in the likelihood of the pa-
tient's having an adverse reaction 
to at least one drug. Of the pa-
tients receiving 16 drugs during 
the period of hospitalization, 45% 
of them will have an adverse reac-
tion to at least one drug that they 
have during the period of hospital-
ization. If I were to recommend 
one thing that would significantly 
reduce the problem of the ill effects 
of drugs, it would be to curtail the 
use of innumerable drugs. This is 
undoubtedly the most important 
factor we have thus far identified. 
Why this curve is logarithmic I 
don't know. Our present feelings 
are that much of this is a problem 
of drug interaction, interactions 
that conceivably have not been 
identified and are unrecognized. 
As you would expect, of course, 
there is a relationship between the 
number of drugs administered and 
the mortality rate and period of 
hospitalization, indicating that peo-
ple who get lots of drugs are gen-
erally the sickest. 
In studies of pneumonia the rate 
of allergic reaction to penicillin 
rarely is less than 10% . Yet in pa-
tients receiving penicillin in V.D. 
clinics, the rate is usually less than 
1 % . Is there a relationship between 
the presence of infection and the 
occurrence of allergic reactions to 
drugs? We have shown such a re-
lationship which I think deserves 
further study. It's our present sup-
position that a severe infection may 
serve as an adjuvant to an im-
munological response to a simple 
chemical agent. 
Over three times more men than 
women receiving penicillin in the 
hospital will have allergic reactions 
to this drug. By history the men in 
this study had received penicillin in 
the past no more frequently than 
women. 
Conclusion 
I would like to conclude by cit-
ing two other rather interesting ob-
servations we have made. Three-
quarters of all the patients in all 
our surveillance who have allergic 
reactions to drugs have had peptic 
ulcer, ulcerative colitis, or neo-
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plastic disease of the gastrointesti-
nal tract. Of these patients, three-
quarters of the drugs producing 
allergic reactions are administered 
orally. The rates of allergic reac-
tions to individual drugs in patients 
with gastrointestinal disease as op-
posed to those without gastroin-
testinal disease receiving the same 
medication, are significantly in-
creased. What the impact is of in-
flammatory gastr,ointestinal disease 
1) upon the absorption of the drug, 
2) upon its metabolism, and 3) 
upon its antigenicity has not been 
investigated before. But from these 
studies it is suggested that inflam-
matory disease of the gastrointesti-
nal tract may be an important fac-
tor predisposing patients receiving 
oral drugs to occurrence of allergic 
reactions. It has commonly been 
supposed that patients with auto-
immunological disorders, e.g., sys-
temic lupus erythematosus, may 
have a predisposition to multiple 
allergic reactions to drugs. In our 
evaluation of this problem, there 
is no significant increase in the oc-
currence of allergic reactions to 
drugs in these patients. 
I would like to end with some 
unresolved questions. We obviously 
need more information on rates of 
reactions to drugs. Without this the 
physician is ill prepared in estimat-
ing risk as opposed to benefit. As 
Col. Moser pointed out, we can go 
20 years before identification of a 
possible relationship of thrombo-
cytopenia to tetracycline. It took 
six years to identify aplastic anemia 
in relation to chloramphenicol. 
There must be some better way to 
identify the ill effects of drugs than 
just by the casual, incidental, peri-
odic reporting in the literature by 
physicians who suspect or identify 
relationships. I happen to think 
this is the greatest value of the 
Food and Drug Administration 
and the AMA Council on Drugs 
Registry on adverse reactions. Un-
fortunately, however, most of the 
reactions reported are those that 
we know exist. As far as I am 
aware, in the FDA program in op-
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eration in a multiplicity of hos-
pitals voluntarily reporting adverse 
effects of drugs has not identified a 
single previously unrecognized ill 
effect of a drug that would not have 
been detected as promptly other-
wise. We need a great deal more 
information about how drugs are 
used outside of the hospital by pa-
tients who can buy them in the 
drug store without prescription. I 
was recently amazed when a phar-
maceutical representative came into 
my office, and I commented about 
how many drugs patients kept in 
their cabinets at home. The phar-
maceutical representative was in-
trigued and came back the follow-
ing day having counted the number 
of drugs in his cabinet-90! It is 
my impression that most of the 
patients who developed Fanconi 
syndrome from outdated tetracy-
cline were children whose mothers 
had been given tetracycline by the 
physician, had kept it on the shelf, 
and then when the child got ill had 
given it to him. I think it's critically 
important that the public be in-
formed as much about the problem 
of drugs as the medical profession. 
We do it poorly. We let journalists 
write about how horrible hospitals 
are, but I have yet to see anybody 
in the medical profession make 
any exertion to inform the public 
about the use of non-prescription 
drugs. We need a great deal more 
information about what heritable 
factors cause reactions to drugs. 
I have indicated some factors 
that suggest this may be far 
more important than we have pre-
viously recognized. We need more 
information on other factors-dis-
eases and organ function-which 
influence predisposition to drug re-
actions. Most studies done on the 
metabolism, absorption, and excre-
tion of drugs are performed in 
normal people. They are not com-
parable to patients in the hospital 
who have fever, renal failure, minor 
abnormalities of liver function, who 
have respiratory embarrassment 
and are in heart failure. We need 
a great deal more information 
about the reactions to drugs in pa-
tients who are sick, as well as we 
need increasing information about 
the problems of drugs in people 
who are well. Thank you. 
